Related references
Note: Only part of the references are listed.A simple, robust, and affordable bioluminescent assay for drug discovery against infective African trypanosomes
Diego Benitez et al.
DRUG DEVELOPMENT RESEARCH (2022)
A profile of research on the parasitic trypanosomatids and the diseases they cause
David Horn
PLoS Neglected Tropical Diseases (2022)
The Evaluation of l-Tryptophan Derivatives as Inhibitors of the l-Type Amino Acid Transporter LAT1 (SLC7A5)
Julien Graff et al.
CHEMMEDCHEM (2022)
An Overview on the Therapeutics of Neglected Infectious Diseases-Leishmaniasis and Chagas Diseases
J. Brindha et al.
FRONTIERS IN CHEMISTRY (2021)
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
Violeta Kourbeli et al.
MOLECULES (2021)
Design, synthesis, and evaluation of novel anti-trypanosomal compounds
Lance T. Lepovitz et al.
TETRAHEDRON (2020)
Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data
Christopher P. Tinworth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design
Lewis D. Pennington et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Mechanistic and biological characterisation of novelN5-substituted paullones targeting the biosynthesis of trypanothione inLeishmania
Andrea Medeiros et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
The Thiol-polyamine Metabolism of Trypanosoma cruzi: Molecular Targets and Drug Repurposing Strategies
Alan Talevi et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Structural Simplification of Natural Products
Shengzheng Wang et al.
CHEMICAL REVIEWS (2019)
Structural simplification: an efficient strategy in lead optimization
Shengzheng Wang et al.
ACTA PHARMACEUTICA SINICA B (2019)
An Overview of Drug Resistance in Protozoal Diseases
Rita Capela et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Drug Discovery for Kinetoplastid Diseases: Future Directions
Srinivasa P. S. Rao et al.
ACS INFECTIOUS DISEASES (2019)
Polyamine-Based Thiols in Trypanosomatids: Evolution, Protein Structural Adaptations, and Biological Functions
Bruno Manta et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region
Nadira D. Karunaweera et al.
PARASITOLOGY (2018)
Challenges and recent progress in drug discovery for tropical diseases
Manu De Rycker et al.
NATURE (2018)
Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro
Federica Ferrigno et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Topliss Batchwise Schemes Reviewed in the Era of Open Data Reveal Significant Differences between Enzymes and Membrane Receptors
Lars Richter
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Neglected tropical diseases: progress towards addressing the chronic pandemic
David H. Molyneux et al.
LANCET (2017)
Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates
Elodie Jagu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
5-Substituted 3-chlorokenpaullone derivatives are potent inhibitors of Trypanosoma brucei bloodstream forms
Oliver C. F. Orban et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
The Halogen Bond
Gabriella Cavallo et al.
CHEMICAL REVIEWS (2016)
Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids
Diego Benitez et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Kei Katsuno et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
Advait S. Nagle et al.
CHEMICAL REVIEWS (2014)
Using Matched Molecular Series as a Predictive Tool To Optimize Biological Activity
Noel M. O'Boyle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Investigation of Indolglyoxamide and Indolacetamide Analogues of Polyamines as Antimalarial and Antitrypanosomal Agents
Jiayi Wang et al.
MARINE DRUGS (2014)
New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents
Bruno Demoro et al.
DALTON TRANSACTIONS (2012)
Paullones as Inhibitors of Protein Kinases
Nadine Tolle et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Targeting Trypanothione Metabolism in Trypanosomatid Human Parasites
Viridiana Olin-Sandoval et al.
CURRENT DRUG TARGETS (2010)
Trypanosomatid Parasites Causing Neglected Diseases
K. Nussbaum et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Chemical Validation of Trypanothione Synthetase A POTENTIAL DRUG TARGET FOR HUMAN TRYPANOSOMIASIS
Leah S. Torrie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Kinetoplastids: related protozoan pathogens, different diseases
Ken Stuart et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Validation of Trypanosoma brucei trypanothione synthetase as drug target
MA Comini et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Solid-phase synthesis of a focused library of trypanothione reductase inhibitors
S De Luca et al.
TETRAHEDRON LETTERS (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25
M Leost et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
